Search Results

There are 2534456 results for: content related to: Quality-of-life and health benefits of early treatment of mild anemia

  1. Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis

    Intervention Review

    The Cochrane Library

    Suetonia C Palmer, Valeria Saglimbene, Dimitris Mavridis, Georgia Salanti, Jonathan C Craig, Marcello Tonelli, Natasha Wiebe and Giovanni FM Strippoli

    Published Online : 8 DEC 2014, DOI: 10.1002/14651858.CD010590.pub2

  2. A Comparison Between Epoetin Omega and Epoetin Alfa in the Correction of Anemia in Hemodialysis Patients: A Prospective, Controlled Crossover Study

    Artificial Organs

    Volume 26, Issue 2, February 2002, Pages: 91–97, Andrej Bren, Aljoša Kandus, Janez Varl, Jadranka Buturović, Rafael Ponikvar, Radoslav Kveder, Stanislav Primožič and Peter Ivanovich

    Article first published online : 22 SEP 2008, DOI: 10.1046/j.1525-1594.2002.06844.x

  3. You have free access to this content
    Does Epoetin Alfa Improve Health-Related Quality of Life in Chronically Ill Patients with Anemia? Summary of Trials of Cancer, HIV/AIDS, and Chronic Kidney Disease

    Value in Health

    Volume 11, Issue 1, January/February 2008, Pages: 57–75, Miriam Kimel, Nancy K. Leidy, Sally Mannix and Julia Dixon

    Article first published online : 25 JUN 2007, DOI: 10.1111/j.1524-4733.2007.00215.x

  4. Darbepoetin for the anaemia of chronic kidney disease

    Intervention Review

    The Cochrane Library

    Suetonia C Palmer, Valeria Saglimbene, Jonathan C Craig, Sankar D Navaneethan and Giovanni FM Strippoli

    Published Online : 31 MAR 2014, DOI: 10.1002/14651858.CD009297.pub2

  5. Erythropoietin or darbepoetin for patients with cancer

    Intervention Review

    The Cochrane Library

    Thomy Tonia, Annette Mettler, Nadège Robert, Guido Schwarzer, Jerome Seidenfeld, Olaf Weingart, Chris Hyde, Andreas Engert and Julia Bohlius

    Published Online : 12 DEC 2012, DOI: 10.1002/14651858.CD003407.pub5

  6. Epoetin alfa corrects anemia and improves quality of life in patients with hematologic malignancies receiving non-platinum chemotherapy

    Hematological Oncology

    Volume 21, Issue 4, December 2003, Pages: 169–180, Timothy J. Littlewood, Johan Nortier, Bernardo Rapoport, Marek Pawlicki, Gilbert De Wasch, Els Vercammen, Wolfgang Schuette, Jacques Wils and Mathias Freund

    Article first published online : 15 JAN 2004, DOI: 10.1002/hon.722

  7. You have free access to this content
    Efficacy of epoetin alfa in the treatment of anaemia of multiple myeloma

    British Journal of Haematology

    Volume 113, Issue 1, April 2001, Pages: 172–179, Franco Dammacco, Gianluigi Castoldi and Stig Rödjer

    Article first published online : 12 JAN 2002, DOI: 10.1046/j.1365-2141.2001.02715.x

  8. You have free access to this content
    Epoetin alfa improves quality of life in patients with cancer

    Cancer

    Volume 101, Issue 8, 15 October 2004, Pages: 1720–1732, Michael Jones, Brad Schenkel, Julie Just and Lesley Fallowfield

    Article first published online : 10 SEP 2004, DOI: 10.1002/cncr.20569

  9. Comparative pharmacokinetics and pharmacodynamics of epoetin alfa and epoetin beta

    Clinical Pharmacology & Therapeutics

    Volume 50, Issue 6, December 1991, Pages: 702–712, Charles E Halstenson, Mark Macres, Stephen A Katz, James R Schnieders, Masakazu Watanabe, Joseph T Sobota and Paul A Abraham

    Article first published online : 3 DEC 1991, DOI: 10.1038/clpt.1991.210

  10. Doping control of biosimilar epoetin kappa and other recombinant erythropoietins after intravenous application

    Drug Testing and Analysis

    Volume 3, Issue 11-12, November-December 2011, Pages: 798–805, Masato Okano, Mitsuhiko Sato, Emi Kaneko and Shinji Kageyama

    Article first published online : 19 OCT 2011, DOI: 10.1002/dta.369

  11. Population Pharmacokinetic Modeling of Epoetin Delta in Pediatric Patients With Chronic Kidney Disease

    The Journal of Clinical Pharmacology

    Volume 48, Issue 7, July 2008, Pages: 837–848, Dr William Knebel, Dr Mary Palmen, Dr James A. Dowell and Dr Marc Gastonguay

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270008318218

  12. Role of oral versus IV iron supplementation in the erythropoietic response to rHuEPO: a randomized, placebo-controlled trial

    Transfusion

    Volume 41, Issue 7, July 2001, Pages: 957–963, Ger Olijhoek, Johannes G.N. Megens, Paulo Musto, Livio Nogarin, Christiana Gassmann-Mayer, Els Vercammen and Sandra A. Hayes-Licitra

    Article first published online : 24 NOV 2002, DOI: 10.1046/j.1537-2995.2001.41070957.x

  13. Comparison between Intravenous and Subcutaneous Recombinant Human Erythropoietin (Epoetin Alfa) Administration in Presurgical Autologous Blood Donation in Anemic Rheumatoid Arthritis Patients Undergoing Major Orthopedic Surgery

    Vox Sanguinis

    Volume 72, Issue 2, February 1997, Pages: 93–100, F. Mercuriali, G. Inghilleri, E. Biffi, M. T. Colotti, A. Vinci, L. Sinigaglia and G. Gualtieri

    Article first published online : 9 MAY 2003, DOI: 10.1046/j.1423-0410.1997.7220093.x

  14. The Effects of Epoetin Alfa on Transfusion Requirements in Head and Neck Cancer Patients: A Prospective, Randomized, Placebo-Controlled Study

    The Laryngoscope

    Volume 112, Issue 7, July 2002, Pages: 1221–1229, Shaun N. Scott, Thomas J. Boeve, Timothy M. McCulloch, Kari A. Fitzpatrick and Lucy H. Karnell

    Article first published online : 2 JAN 2009, DOI: 10.1097/00005537-200207000-00015

  15. You have free access to this content
    What are cancer patients willing to pay for prophylactic epoetin alfa?

    Cancer

    Volume 83, Issue 12, 15 December 1998, Pages: 2588–2596, Ana Ortega, George Dranitsaris and Anitasha L. V. Puodziunas

    Article first published online : 9 NOV 2000, DOI: 10.1002/(SICI)1097-0142(19981215)83:12<2588::AID-CNCR26>3.0.CO;2-M

  16. Recombinant human erythropoietin in pediatric oncology: A review

    Medical and Pediatric Oncology

    Volume 39, Issue 4, October 2002, Pages: 463–468, James Feusner and Caroline Hastings

    Article first published online : 29 AUG 2002, DOI: 10.1002/mpo.10187

  17. What is the practical conversion dose when changing from epoetin alfa to darbepoetin outside of clinical trials?

    Nephrology

    Volume 9, Issue 4, August 2004, Pages: 223–228, SIMON D ROGER and BRUCE COOPER

    Article first published online : 8 SEP 2004, DOI: 10.1111/j.1440-1797.2004.00261.x

  18. Epoetin alfa for the Treatment of Combination Therapy–Induced Hemolytic Anemia in Patients Infected with Hepatitis C Virus

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 25, Issue 6, June 2005, Pages: 862–875, Dr. Anastasia M. Rivkin and Sweta Chawla

    Article first published online : 16 JAN 2012, DOI: 10.1592/phco.2005.25.6.862

  19. Is epoetin alfa a treatment option for chemotherapy-related anemia in children?

    Medical and Pediatric Oncology

    Volume 39, Issue 4, October 2002, Pages: 455–458, Münevver Büyükpamukçu, Ali Varan, Tezer Kutluk and Canan Akyüz

    Article first published online : 29 AUG 2002, DOI: 10.1002/mpo.10185

  20. Australian haemodialysis patients on intravenous epoetin alfa or intravenous darbepoetin alfa: How do they compare?

    Nephrology

    Volume 12, Issue 2, April 2007, Pages: 126–129, BRUCE A PUSSELL, ROWAN WALKER and THE AUSTRALIAN RENAL ANAEMIA GROUP

    Article first published online : 6 FEB 2007, DOI: 10.1111/j.1440-1797.2006.00762.x